We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ask ADVFN Intelligence (AI)
NEW HAVEN, Conn. and TOKYO, Oct. 3 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into an agreement with Sankyo, Co., Ltd...
NEW HAVEN, Conn. and TOKYO, Sept. 21 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into a pharmacogenomic research collaboration...
NEW HAVEN, Conn., and MARSEILLE, France, Sept. 12 /PRNewswire-FirstCall/ -- Privately-held Ipsogen SAS and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that they have signed...
- Increases Presence in EU Ag Genotyping Market - NEW HAVEN, Conn., Aug. 23 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that it will provide its...
- Will Address EU Mandate for Sheep-Breeding Programs That Confer Resistance to Scrapie - NEW HAVEN, Conn., Aug. 11 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC...
Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon NEW HAVEN, Conn. and OSS, Netherlands, July 18 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals...
Clinical Data to Acquire Genaissance Pharmaceuticals Combined Company to Deliver Industry-Defining Theranostics NEWTON, Mass., and NEW HAVEN, Conn., June 21 /PRNewswire-FirstCall/ -- Clinical...
Clinical Data, Inc. (NASDAQ:CLDA) and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that they have signed an agreement for Clinical Data to acquire Genaissance Pharmaceuticals in...
Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner NEW HAVEN, Conn., June 7 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced...
Genaissance Reports First Quarter 2005 Results Company Cites Progress In Key Areas, Including Recent Increase In Cash Reserves NEW HAVEN, Conn., May 3 /PRNewswire-FirstCall/ -- Genaissance...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
DougS.
20 years ago
gator16
20 years ago
DougS.
20 years ago
gator16
20 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
